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Results (Cont.)
The gut microbiome affects many aspects of human health including response to cancer treatments. Recent work has
demonstrated that certain gut bacteria modulate response to immune checkpoint inhibitors1 (ICIs), and, in mice, response to
ICIs can be increased by increasing the abundance of probiotics2. Diet-based interventions hold promise for translating
microbiome modification into a clinical setting; however, progress has unfortunately been slowed by a lack of evidence
regarding the ways in which specific food products can affect microbes, particularly in complex communities such as the gut.
Increasing the abundance of probiotics thus represents a promising approach to modulate the likelihood of response to ICIs
in humans. As such, it is important to maintain a healthy gut microbiota and correct any dysbiosis as it serves important
functions in maintaining the gut barrier’s structural integrity, and enhance responses to certain cancer treatments3,4. As
reported elsewhere, the density of probiotics can be influenced by dietary interventions such as fruits rich in polyphenols5.
The objective of the project focuses on the use of novel in vitro human colonic model to simulate a colon environment
without the interference from the host, to study the interaction between gut microbe and polyphenol-rich black raspberry
(BRB) extract and characterization of its metabolites. This will provide insights on how dysbiosis in cancer patient might be
corrected using food interventions and the roles played by the associated phenolic compounds. Additional metagenomic





Figure 3. VIP score plot shown the top 5 metabolites that
drive the distinct changes in metabolic profile in A)
ascending colon; B) transverse colon; and C) descending
colon during the pretreatment phase and treatment phase.
D shown the location comparison analysis of the colon
during treatment phase.
Figure 4. Heat map showing the changes in the amount of
phenolic compounds found in colon between treatment
and washout phase. A) ascending colon; B) transverse
colon; and C) descending colon.
Figure 2. A: PLSDA plot of intracellular polar
metabolite profile between pre-treatment and
treatment phases in A) ascending colon; B)
transverse colon; and C) descending colon. Clear
separation in PLSDA plot means distinctly changed
metabolic profile after BRB intervention. D) PLSDA
plot of locational comparison in three colon sections
during treatment phase.
Microbial experiments:
1. A customized human colonic model was
established using automatic control modules, a
series of bioreactors, and operated in anaerobic
conditions at 37°C without light exposure.
2. Microbiome from lung cancer patient was
extracted from fecal sample and cultured
overnight in anaerobic chamber. 3 ml of bacteria
culture was added to each vessels.
3. HCM was run for 6 weeks, with 2 weeks of pre-
treatment, 2 weeks of treatment and 2 weeks of
post treatment, samples were collected and
analysed. 5ml/L of black raspberry extract was
added to the feeding media as treatment.
Samples were collected and stored in -80 ℃ for
further analysis.
4. Gut microbial population and diversity were
measured via 16s rRNA gene sequencing and
transcriptomic analysis was performed to
measure the changes in gene expression.
Mass spectrometry experiments:
1. Authentic metabolites standards were used to
establish the targeted compound detection.
2. A Vanquish UHPLC Systems coupled with Q
Exactive UHMR hybrid Qudrupole-Orbitrap MS
System from ThermoFisher Scientific were used for
metabolomics analysis.
3. Data were analyzed in Compound Discover
software and MetaboAnalyst for statistical analysis.
Results
Figure 1. The schematic of this study
Figure 5. Short-Chain Fatty acid (SCFA) analysis during
pre-treatment, treatment and post-treatment phases in
ascending colon. Statistical analysis shown that propionic
acid, isobutyric acid, 2-methylbutyric acid and hexanoic
acid shown a significant increase in concentration between
pre-treatment to treatment phase in asceding colon (t-test p
<0.05). Isovaleric acid and valeric acid also shown a
significant increase in their concentration (t-test p <0.01).
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Human Colonic Model Target metabolite analysis Statistical analysis
Summary & Future Directions
• 6 out of 8 SCFA metabolites were detected at higher
relative abundance after BRB treatment, showing that
there is a polyphenol-driven change in the metabolic profile
of the microbiome.
• Additional metagenomic analysis is currently ongoing and
will provide a better understanding of how different gut
microbes respond to the addition of black raspberry
extract.
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